Pharma Co. Impel's Ch. 11 Liquidation Plan Approved
Migraine-drug maker Impel Pharmaceuticals received confirmation of its Chapter 11 liquidation plan on Monday after selling its assets and making changes to the plan's exculpation provisions in response to a U.S....To view the full article, register now.
Already a subscriber? Click here to view full article